Polyphenols and Ischemic Stroke: Insight into One of the Best Strategies for Prevention and Treatment.
Francesca PacificiValentina RovellaDonatella PastoreAlfonso BelliaPasquale AbeteGiulia DonadelSilvia SantiniHeinz BeckCamillo RicordiNicola Di DanieleDavide LauroDavid Della-MortePublished in: Nutrients (2021)
Ischemic stroke (IS) is still among the leading causes of death and disability worldwide. The pathogenic mechanisms beyond its development are several and are complex and this is the main reason why a functional therapy is still missed. The beneficial effects of natural compounds against cardiovascular diseases and IS have been investigated for a long time. In this article, we reviewed the association between the most studied polyphenols and stroke protection in terms of prevention, effect on acute phase, and rehabilitation. We described experimental and epidemiological studies reporting the role of flavonols, phenolic acid, and stilbens on ischemic mechanisms leading to stroke. We analyzed the principal animal models used to evaluate the impact of these micronutrients to cerebral blood flow and to molecular pathways involved in oxidative stress and inflammation modulation, such as sirtuins. We reported the most significant clinical trials demonstrated as the persistent use of polyphenols is clinically relevant in terms of the reduction of vascular risk factors for IS, such as Atrial Fibrillation. Interestingly, different kinds of polyphenols provide brain protection by activating different pathways and mechanisms, like inducing antithrombotic effect, such as Honokiol. For this reason, we discussed an appropriate integrative use of them as a possible therapeutic alternative against stroke.
Keyphrases
- atrial fibrillation
- oxidative stress
- oral anticoagulants
- catheter ablation
- left atrial
- left atrial appendage
- direct oral anticoagulants
- clinical trial
- cerebral blood flow
- heart failure
- cardiovascular disease
- percutaneous coronary intervention
- cerebral ischemia
- multiple sclerosis
- randomized controlled trial
- stem cells
- white matter
- atomic force microscopy
- combination therapy
- high resolution
- coronary artery disease
- endoplasmic reticulum stress
- phase ii
- phase iii
- blood brain barrier
- network analysis
- electronic health record
- acute coronary syndrome
- double blind